Sigal Katz, Ph.D.

Senior Client Strategist

Dr. Sigal Katz received her Ph.D. in Molecular Biology from the Technion-Israel Institute of Technology, focusing her research on signal transduction pathways involved in breast cancer. Dr. Katz was a Postdoctoral research associate at Prof. Penn’s lab from University of Toronto, located at the Ontario Cancer Institute. Dr. Katz’s research focused on regulation and function of c-myc and the development of novel anti-cancer therapeutics.

Dr. Katz served as an equity analyst for one of the leading financial institutes in Israel, specializing in life-science companies in general and oncology and medical device companies in particular. Prior to her work in the financial industry, Dr. Katz served as a marketing manager in Patho-Lab Diagnostics, Israel’s largest provider of clinical laboratory services for Histopathology and Cytopathology.

Dr. Katz is the recipient of many awards and honors and has authored and co-authored numerous publications.